Table 3. Pooled phenotypic proportions.
| P (95%CI) | |||||||
|---|---|---|---|---|---|---|---|
| Phenotype | Serotype | N | K | P | L | U | OR (95%CI) |
| MDR | S. Typhimurium | 800 | 5 | 89.3 | 84.8 | 93.1 | Tp vs.Ty; 15.6 (11.8,20.5) |
| S. Enteritidis | 530 | 5 | 68.5 | 47.1 | 86.6 | ||
| S. Typhi | 836 | 11 | 34.8 | 22.3 | 48.5 | ||
| Overall | 2166 | 21 | 57.4 | 44.9 | 69.5 | ||
| Cipns | S. Typhimurium | 800 | 5 | 2.9 | 1.8 | 4.1 | Ty vs. Tp; 3.3 (2,5.5) |
| S. Enteritidis | 530 | 5 | 4.6 | 0.1 | 14.8 | ||
| S. Typhi | 836 | 11 | 8.9 | 3 | 17.6 | ||
| Overall | 2166 | 21 | 6.2 | 2.8 | 10.7 | ||
| MDR-Cipns | S. Typhimurium | 800 | 5 | 2.6 | 1.6 | 3.9 | |
| S. Enteritidis | 530 | 5 | 1 | 0 | 2.8 | ||
| S. Typhi | 836 | 11 | 5.9 | 2.1 | 11.4 | ||
| Overall | 2166 | 21 | 3.8 | 1.8 | 6.5 | ||
| nMDR-Cipns | S. Typhimurium | 800 | 5 | 0.4 | 0 | 1 | |
| S. Enteritidis | 530 | 5 | 5.2 | 0 | 17.9 | ||
| S. Typhi | 836 | 11 | 3.5 | 0.7 | 8.4 | ||
| Overall | 2166 | 21 | 2.7 | 0.9 | 5.3 | ||
| Inv-salm | iNTS | 47337 | 11 | 1.9 | 0.7 | 3.6 | NTS vs. TyS; 1.1(0.98,1.2) |
| Typhoidal | 47337 | 11 | 1.7 | 1.1 | 2.5 | ||
| Overall | 47337 | 11 | 1.8 | 1.1 | 2.6 | ||
Cipns; ciprofloxacin non-susceptible; Inv-salm, invasive salmonellosis; K, number of studies; L, lower limit; MDR, multi-drug resistant; MDR-Cipns; multi-drug resistant + ciprofloxacin non-susceptible; N, number of isolates; nMDR-Cipns; non-multidrug resistant + ciprofloxacin non-susceptible; NTS, non-typhoidal Salmonella; OR, odds ratio; P, pooled proportion; Q, Cochran’s-test; T2, tau squared; Tp, S. Typhimurium; Ty, S. Typhi; TyS, typhoidal Salmonella; U, upper limit.